A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma

NCT00733798 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

58

Enrollment

INDUSTRY

Sponsor class

Stopped For Strategic Reasons

Conditions

Melanoma
Malignant Melanoma
Metastatic Melanoma

Interventions

DRUG: 131I-TM601

Sponsor

TransMolecular